A Study of an Intratumoral Oncolytic Virus in Patients with Advanced Metastatic Solid Tumors

Trial Identifier: 9801-CL-0101
Sponsor: Astellas Pharma Global Development, Inc.
Collaborator:
Merck Sharp & Dohme LLC
Start Date: September 2019
Primary Completion Date: April 2024
Study Completion Date: April 2024
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States of America, AL Birmingham, AL, United States of America, 35233
United States of America, Arizona Tucson, Arizona, United States of America, 85719
United States of America, CA Los Angeles, CA, United States of America, 90025
United States of America, IL Chicago, IL, United States of America, 60637
United States of America, Kentucky Louisville, Kentucky, United States of America, 40241
United States of America, KY Lexington, KY, United States of America, 40536
United States of America, Maryland Baltimore, Maryland, United States of America, 21201
United States of America, MI Detroit, MI, United States of America, 48202
United States of America, MN Minneapolis, MN, United States of America, 55455
United States of America, NE Omaha, NE, United States of America, 68130
United States of America, New York Buffalo, New York, United States of America, 14263
United States of America, PA Philadelphia, PA, United States of America, 19111
United States of America, PA Pittsburgh, PA, United States of America, 15260
United States of America, TX Dallas, TX, United States of America, 75251
United States of America, TX Houston, TX, United States of America, 77030
United States of America, VA Richmond, VA, United States of America, 23298
United States of America, Virginia Charlottesville, Virginia, United States of America, 22903